Dublin, March 27, 2026 (GLOBE NEWSWIRE) — The “Clinical Nutrition Market Report 2026” has been added to the ResearchAndMarkets.com’s offer.
The clinical nutrition market has grown significantly in recent years, advancing from $64.37 billion in 2025 to $70.42 billion by 2026, at a CAGR of 9.4%. This growth is due to factors such as the limited availability of special nutritional products and the expansion of hospitals and clinical infrastructure. As the prevalence of chronic disease increases and awareness of malnutrition increases, enteral and parenteral solutions become the standard.
The market is expected to reach around $102.42 billion by 2030, maintaining a steady CAGR of 9.8%. This anticipated growth comes from the development of specialized and disease-specific nutritional formulas, the expansion of home care and tele-nutrition services, and increased adoption of digital monitoring devices.
Key trends shaping the future include rising demand for infant nutrition products, increased adoption of specialty formulas in hospitals, and growth in tailored nutritional therapies for cancer and metabolic disorders. The integration of home care and remote nutrition monitoring services, and the expansion of clinical nutrition programs for geriatrics and adults, further supports this trajectory.
The increasing geriatric population, a key market driver, often requires special nutritional care due to vulnerability to age-related health problems. Statistics from the Office for National Statistics show an increase in the population aged 90 and over in the UK, contributing to an increase in demand for clinical nutrition. The geriatric demographic benefits from tailored dietary solutions to maintain health and manage chronic conditions.
Innovations in technological solutions, such as semi-solid enteral nutrition formulations, address the need for patient-friendly options. This product lowers the risk of reflux, improves gastric tolerance, and improves nutrient absorption. For example, Otsuka Pharmaceutical Factory Inc. introducing ENOSOLID Semi Solid for Enteral Use, a gel-like formulation aimed at meeting dietary needs while reducing energy expenditure.
Strategic industry moves, such as Danone SA’s acquisition of a majority stake in Kate Farms Inc., underscore the market shift toward integrating organic and plant-based nutritional products into clinical practice. This partnership strengthens Danone’s presence in the US medical nutrition sector, enhancing its portfolio with Kate Farms’ innovative formulations.
Major players in this dynamic market include Abbott Laboratories, Nestle SA, Baxter Healthcare Ltd., Danone SA, and Fresenius Kabi AG, among others. North America leads the market in 2025, with widespread coverage in Asia-Pacific, Europe, and beyond.
Tariffs pose challenges, increasing costs for imported raw materials and specialty formulations. However, they also encourage local manufacturing and domestic innovation. As a hub for clinical nutrition insights, the market research report offers a comprehensive overview of market size, regional shares, and trends. As the market evolves, the demand for appropriate nutrition in combating metabolic disorders and supporting vulnerable populations remains a critical focus.
Scope of the Report
The report is essential to identify the largest and fastest growing markets in clinical nutrition, understand the market’s interactions with the broader economy, demographics, and parallel markets. It evaluates technological disruption, regulatory shifts, and changing consumer preferences.
Key areas covered in the report include market characteristics, size and growth, segmentation, regional and country, TAM, market attractiveness score (MAS), competitive landscape, market share, company scoring matrix, trends, and strategic recommendations.
Supply chain analysis examines the value chain, raw materials, resources, and market competitors.
Trends and strategies focus on digital transformation, automation, sustainability initiatives, and AI-driven innovation. Strategies to take advantage of these developments for market positioning are provided.
Regulatory and investment scenarios examine key frameworks and funding trends driving industry growth.
The forecast considers current influencing factors, including technological developments, geopolitical dynamics, and economic indicators.
TAM analysis provides strategic insights and growth opportunities.
The market attractiveness score provides a numerical framework that addresses growth potential, strategic fit, and competitor dynamics.
Segmentation groups markets into specific sub-markets, analyzing growth across regions and countries.
Regional coverage expands to include Taiwan and Southeast Asia, recognizing its emerging role in global value chains.
The competitive landscape evaluates the nature of the market, shares, and description of the leading company, while the company scores a matrix of company costs based on market share, innovation, and brand recognition.
Markets Covered:
Based on Product: Infant Nutrition, Parenteral Nutrition, Enteral Nutrition
By Route of Administration: Oral, Enteral, Parenteral
By Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Other Applications
By End User: Pediatric, Adult, Geriatric
Subsegments: Infant Formula, Baby Food, Nutritional Supplements, and more
Company Named: Abbott Laboratories, Nestle SA, Baxter Healthcare Ltd., and others.
Countries and Areas Covered: Australia, Brazil, China, France, Germany, and key regions like Asia-Pacific, North America, etc.
Time series: Includes five years of historical and ten years of forecast data.
Data Source: The report uses a qualified data sourcing strategy, with end notes provided for all data points.
Delivery Format: Available in Word, PDF, or Interactive Reports and Excel Dashboards.
Added Benefits:
Key attributes
Report Attributes
details
Number of Pages
250
Forecast Period
2026-2030
Estimated Market Value (USD) in 2026
$70.42 Billion
Forecast Market Value (USD) by 2030
$102.42 Billion
Compound Annual Growth Rate
9.8%
Area Covered
Global
Companies featured in this Clinical Nutrition market report include:
Abbott Laboratories
Nestle SA
Baxter Health Ltd.
B. Braun Melsungen AG
The company Perrigo plc
Fresenius Kol AG
Danone SA
Pfizer Inc.
Mead Johnson Nutrition Company
Nutrition Hero
Gentiva Health Services Inc.
HJ Heinz Company
Ajinomoto Co. Speaking.
Lonza Group Ltd.
GlaxoSmithKline plc
BASF SE
Kendal Nutricare
DuPont Nutrition & Health
American HomePatient
Reckitt Benckiser Group plc
Vivant Health
For more information on this report visit https://www.researchandmarkets.com/r/xm9eh0
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For Office Hours EST Call 1-917-300-0470 For US/CAN Toll Free Call 1-800-526-8630 For Office Hours GMT Call +353-1-4016-89
